Our data showed that treatment with PD-L1-Fc/Oxi-αCD nanoparticles increased the content of SCFAs in the feces of mice with colitis, which was accompanied by an increase in the proportion of some T lymphocytes in the colonic lamina propria, as well as an increase in IL-10 concentrations. Here, CD274 is linked to colitis.